Powder: -20°C for 3 years | In solvent: -80°C for 1 year
QL-X-138 HCl is a novel selective and highly potent BTK/MNK dual-kinase inhibitor with anticancer activity that binds covalently to BTK and noncovalently to MNK. QL-X-138 HCl inhibited BTK, MNK1, and MNK2 kinases. QL-X-138 HCl has anti-dengue virus 2 activity and shows anti-proliferative activity in acute myeloid leukemia cells. QL-X-138 HCl can be used to study lymphoma and leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 483.00 | |
10 mg | In stock | $ 692.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,490.00 |
Description | QL-X-138 HCl is a novel selective and highly potent BTK/MNK dual-kinase inhibitor with anticancer activity that binds covalently to BTK and noncovalently to MNK. QL-X-138 HCl inhibited BTK, MNK1, and MNK2 kinases. QL-X-138 HCl has anti-dengue virus 2 activity and shows anti-proliferative activity in acute myeloid leukemia cells. QL-X-138 HCl can be used to study lymphoma and leukemia. |
Targets&IC50 | BTK Y223:11 nM (EC50), PLCγ2 Y1217:57 nM (EC50) |
In vitro | In Ramos, OCI-AML3, U2932, TMD8, and U937 cells, QL-X-138 HCl(3-10000 nM; 4 hours) significantly inhibited the auto-phosphorylation of BTK Y223 (EC50=11 nM).QL-X-138 HCl strongly blocked the phosphorylation of the BTK downstream target PLCγ2 Y1217 (EC50=57 nM) and suppressed the phosphorylation of the MNK downstream target eIF4E S209 at a concentration of 1 μM[1]. |
Synonyms | QL-X-138 HCl(1469988-63-3 Free base) |
Molecular Weight | 457.91 |
Formula | C25H20ClN5O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
QL-X-138 HCl Angiogenesis MAPK Tyrosine Kinase/Adaptors MNK BTK QL-X-138 HCl(1469988-63-3 Free base) inhibitor inhibit